Literature DB >> 21844408

Familial clustering of hemangiomas.

J Fredrik Grimmer1, Marc S Williams, Richard Pimentel, Geraldine Mineau, Grant M Wood, Pinar Bayrak-Toydemir, David A Stevenson.   

Abstract

OBJECTIVES: To assess the degree of relationship among individuals with hemangiomas and to evaluate the relative risk (RR) for family members of individuals with hemangiomas.
DESIGN: Retrospective case-control study.
SETTING: Utah Population Database. PARTICIPANTS: Data sets of individuals of different ages with International Classification of Diseases, Ninth Revision (ICD-9) codes for hemangiomas were created from sources having medical records linked to the Utah Population Database. Controls were selected who matched cases for sex, birth year, and birthplace inside vs outside of Utah. Ten controls were selected per case, and sampling was performed without replacement. Kinship analysis tools were used to identify pedigrees having excess individuals with hemangiomas. MAIN OUTCOME MEASURE: Using conditional logistic regression analysis, RR for hemangiomas among several kinship classes was determined.
RESULTS: Identified were 2514 distinct cases 12 years or younger with ICD-9 code 228.01, and the RR for sibs in this group was significantly increased (RR, 2.52; P < .001). Seventy-three founder families had 5 or more affected descendants with cluster P values ≤ .01; familial standardized incidence ratios ranged from 1.64 to 9.50. Family sizes ranged from 546 to 22 291 descendants.
CONCLUSIONS: Sibs have increased RR for infantile hemangiomas, suggesting a potential genetic contribution to this likely multifactorial disease. Identification of large families with distantly related individuals will be helpful for future shared segment identification analyses.

Entities:  

Mesh:

Year:  2011        PMID: 21844408     DOI: 10.1001/archoto.2011.91

Source DB:  PubMed          Journal:  Arch Otolaryngol Head Neck Surg        ISSN: 0886-4470


  4 in total

1.  Maternal and Perinatal Risk Factors for Infantile Hemangioma: A Matched Case-Control Study with a Large Sample Size.

Authors:  Xue Gong; Tong Qiu; Liwei Feng; Kaiying Yang; Shiyi Dai; Jiangyuan Zhou; Xuepeng Zhang; Siyuan Chen; Yi Ji
Journal:  Dermatol Ther (Heidelb)       Date:  2022-06-25

Review 2.  Pathogenesis of infantile haemangioma.

Authors:  S Greenberger; J Bischoff
Journal:  Br J Dermatol       Date:  2013-07       Impact factor: 9.302

3.  VEGF Pathway Gene Expression Profile of Proliferating versus Involuting Infantile Hemangiomas: Preliminary Evidence and Review of the Literature.

Authors:  Rodica Elena Heredea; Eugen Melnic; Laura Elena Cirligeriu; Patricia Lorena Berzava; Maria Corina Stănciulescu; Călin Marius Popoiu; Anca Maria Cimpean
Journal:  Children (Basel)       Date:  2022-06-17

4.  Propranolol treatment of infantile hemangioma endothelial cells: A molecular analysis.

Authors:  Jessica Stiles; Clarissa Amaya; Robert Pham; Rebecca K Rowntree; Mary Lacaze; Arlynn Mulne; Joyce Bischoff; Victor Kokta; Laura E Boucheron; Dianne C Mitchell; Brad A Bryan
Journal:  Exp Ther Med       Date:  2012-08-03       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.